Bill > SB17

This bill modifies Missouri's regulations on opioid prescriptions by establishing more stringent requirements for healthcare practitioners when prescribing opioid controlled substances. The bill limits initial opioid prescriptions for acute pain to a seven-day supply, with exceptions for patients undergoing cancer treatment, receiving hospice or palliative care, residing in long-term care facilities, or being treated for substance abuse. Before issuing an initial or third prescription for a Schedule II controlled substance or opioid pain reliever, practitioners must now have a detailed discussion with patients (or their guardians if the patient is a minor) about the risks of addiction, overdose, potential alternative treatments, and the dangers of mixing opioids with other substances like alcohol or benzodiazepines. Practitioners must document this consultation in the patient's medical record. The bill also maintains existing provisions that limit the quantity of controlled substances that can be prescribed at one time, with Schedule II substances limited to a 30-day supply and Schedule III-V substances limited to a 90-day supply. Additionally, pharmacists are protected from disciplinary action when dispensing or refusing to dispense medication in good faith according to these new guidelines.

Health and Social Services

https://www.senate.mo.gov/25info/BTS_Web/Bill.aspx?SessionType=R&BillID=75